With regard to the impact on survival of p53, c-erbB-2 and EGFR expression, patients presenting head and neck squamous cell carcinomas with p53 and absence of EGFR expression had a better survival rate (75.0%) than for the remaining group (33.1%). Here, EGFR is linked to head and neck squamous cell carcinoma.